Hello, Fool! | Login | Signup | My Fool
Sep 7, 2008 8:30 AM ET | Site Changes | Help
A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.
View All Commentary (IMCL)
Recs
damnishoulda (70.24) Submitted: 3/23/07 9:29 PM : Start Price: $38.45 IMCL Score: 79.30
Another Icahn holding... Call me "the sheepster", but when Icahn has $400m bet on something - I gotta fold.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK